COVID-19 Funding Opportunities
The National Institutes of Health (NIH) offers a list of funding opportunities for medical researchers focused on Coronavirus Disease (COVID-19). For detailed information, please visit the NIH grants website.
Below please find funding opportunities available to medical researchers specific to the Coronavirus Disease (COVID-19).
| Organization(s) | Title | Notice Number | Expiration Date | Activity Code(s) |
| NCATS, NIAMS, NICHD, NIDCR, NIGMS, NIMHD, OBSSR, ORWH | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) | PAR-22-167 | 10/18/2024 | UG3/UH3 |
| NIMH | Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research | NOT-MH-22-100 | 01/08/25 | R21, R34, R01 |
| NHLBI | Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups | NOT-HL-22-010 | 05/08/25 | R01 |
| NHLBI, NICHD, NIAID | Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection | NOT-HL-22-004 | 09/08/25 | R01, R21 |
| NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) | PA-20-135 | 09/08/25 | 333 |
| Office of Biomedical Advanced Research and Development Authority (BARDA) ǀ Broad Agency Announcement (BAA) | BARDA expanded its standard broad agency announcement (BAA) to accept proposals for advanced development of diagnostics, vaccines, therapeutics and other medical products for use in the current COVID-19 emergency response and future coronavirus outbreaks. | |||
| National Science Foundation (NSF) (NSF) | NSF Rapid Response Research (RAPID) funding mechanism for non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. |